January is dedicated to raising awareness about cervical cancer, a curable and preventable disease caused by human papillomaviruses (HPV). It is the fourth most commonly diagnosed cancer among women.
Cervical Cancer Awareness Month in January raises awareness of cervical cancer, which can be prevented and treated early. Cervical cancer screening detects cervix and cell abnormalities.
For women, cervical cancer affects the cervix, the lowest part of the uterus. It can infect the lungs, bladder, rectum, and vagina. This is the fourth most common female cancer. The main cause of cervical cancer is HPV. Sexually transmitted HPV is straightforward to treat early.
Apollo Diagnostics National Technical Head & Chief Pathologist Dr. Rajesh Bendre warns that untreated it could lead to cervical cancer and other major issues. Successful immunization, continued screening, and improved diagnostics have lowered mortality. Thus, women must obtain cervical cancer screenings at a certain age. Women over 35 are at higher risk for cervical cancer, but screening can detect and cure it early.
Prevention and treatment of cervical cancer require early detection and treatment. Cervix and cell abnormalities can be detected by advanced screening, reducing HPV and cancer risk.
Papanicolaou (Pap smear) tests are often performed to detect cervical cell abnormalities that could develop to cancer. Women 30 and older should have it and HPV tests every 5 years. Risk factors may lead doctors to prescribe more frequent testing.
Women 26-30 receive VIA screening to detect cervical lesions by visually inspecting the cervix with acetic acid. This simple treatment and reliable diagnosis of early cervical cancer indications allow women who test positive to receive cryotherapy promptly.
Remote women with limited resources benefit from this test that detects precancerous cervical lesions.
HPV testing finds cervical cancer-causing HPV. HPV diagnosis early reduces cervical cancer risk and guides treatment. At least 10 years pass before HPV turns cancer, allowing diagnosis and treatment.
Cervical cancer screening at 21 is essential for women’s health, regardless of sexuality. Age and medical history dictate screening type and frequency. Pap tests every three years are advised for 21-29-year-olds. Women 30-65 can pick Pap every 3 years and HPV every 5 years or co-testing. Doctors should choose the optimal screening schedule.
Conclusion
Cervical Cancer Awareness Month in January raises awareness of cervical cancer, which can be prevented and treated early. Cervical cancer, the fourth most common cancer in women, affects the cervix and cells. HPV, spread through sexual contact, is the main cause and easily treated early. Untreated, it can become cervical cancer and be serious. Regular screening, vaccination, and improved diagnostics have lowered mortality. No matter sexual behavior, women should get screened at 21. Age and medical history dictate screening type and frequency. Women aged 21–29 should have Pap tests every 3 years, whereas those aged 30-65 can co-test or have Pap tests every 3 years
